Multi-omics profiling reveals dysregulated ribosome biogenesis and impaired cell proliferation following knockout of CDR2L. Solheim ET, Gerking Y, Krakenes T, Herdlevaer I, et al. BMC Cancer 2024;24:645.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Solheim ET, Gerking Y, Krakenes T, Herdlevaer I, et al. Multi-omics profiling reveals dysregulated ribosome biogenesis and impaired cell proliferation following knockout of CDR2L. BMC Cancer 2024;24:645.
PMID: 38802745